AAPS 25th Anniversary. Developing Science. Impacting health.

2012 AAPS National Biotechnology Conference

May 21–23, 2012
Sheraton San Diego Hotel and Marina, San Diego 

Program

Final Programs

 
AAPS Workshop on Formulation Strategies for Nonparenteral Drug Delivery of Biotherapeutics 

• Final Program with handouts (21MB)        
• Final Program without handouts (8MB)

AAPS Workshop on Clinical Pharmacology and ADME of Biotherapeutic Proteins 

• Final Program with handouts (25 MB)
• Final Program without handouts (10MB)

Advanced Immunogenicity Training Course  

• Final Program with handouts (39MB)
• Final Program without handouts (7MB)

Short Course 1: Practical Essentials of Design of Experiments (DoE) toward Robust Bioanalysis 

• Final Program with handouts (4.2MB)
• Final Program without handouts (4MB)

Short Course 2: Biosimilars  

• Final Program with handouts (0.5MB)
• Final Program without handouts (0.5MB)

Short Course 3: Translational Challenges in Developing Antibody-drug Conjugates 

• Final Program with handouts (5MB)
• Final Program without handouts (5MB) 

 

Conference

Call for Papers/Program-at-a-Glance 

• Preliminary Program—Sessions will cover diverse topics, such as diversity and complexity of vaccine manufacturing, scale-up and tech transfer strategies, applications of multi-scale systems pharmacology, and advancements in novel small protein therapeutic modalities.

 

New Course

• Advanced Immunogenicity Training Course  

 

Workshops

• AAPS Workshop on Formulation Strategies for Nonparenteral Drug Delivery of Biotherapeutics 
• AAPS Workshop on Clinical Pharmacology and ADME of Biotherapeutic Proteins 

 

Short Courses

• Short Course 1: Practical Essentials of Design of Experiments (DoE) toward Robust Bioanalysis 
• Short Course 2: Biosimilars 
• Short Course 3: Translational Challenges in Developing Antibody-drug Conjugates 

 

Hot Topics

• Formation of Biosimilars Action Program Committee  
• Immunogenicity to the "Non-business" Region(s) of the Biotherapeutic: When Should We Care? 
• Design, Evaluation, and Characterization of USP <1050.1> Viral Clearance Procedures 
• Post Market Immunogenicity Monitoring: An Emerging Need  

 

  

 Meet the speakers at BioTalk (PDF) »

 

 

My Itinerary—contributed paper abstracts, speaker bios and abstracts, committee meetings, and more. NOW OPEN!